The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dreyfus, D. H.
Right arrow Articles by Gelfand, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dreyfus, D. H.
Right arrow Articles by Gelfand, E. W.
The Journal of Immunology, 1999, 163: 6261-6268.
Copyright © 1999 by The American Association of Immunologists

Inactivation of NF-{kappa}B by EBV BZLF-1-Encoded ZEBRA Protein in Human T Cells1

David H. Dreyfus, Masayuki Nagasawa, Joanne C. Pratt, Colm A. Kelleher and Erwin W. Gelfand2

Division of Basic Sciences, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206

We have previously shown that the EBV ZEBRA protein (also denoted EB1, Z, or Zta) encoded by the BZLF open reading frame is expressed in primary human thymocytes and in human T lymphoblastoid cell lines infected by EBV. Expression of EBV-encoded gene products in T lymphocytes could contribute to viral pathogenesis during acute EBV infection as well as in individuals coinfected with EBV and HIV. HPB-ALL and Jurkat T lymphoblastoid cell lines transiently and stably expressing ZEBRA were characterized in this work. Expression of ZEBRA protein in human T lymphoblastoid cells was associated with decreased expression of an NF-{kappa}B reporter gene, altered expression of the NF-{kappa}B p50 protein subunit, and decreased DNA binding by components of NF-{kappa}B. These observations suggest that inactivation of NF-{kappa}B transcription by ZEBRA in EBV-infected T cells may be a novel mechanism of viral pathogenesis analogous in part to over-expression of the endogenous cytoplasmic inhibitor of NF-{kappa}B, I{kappa}B{alpha}.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Li, L. Qian, C. Chen, M. Shi, M. Yu, M. Hu, L. Song, B. Shen, and N. Guo
Down-Regulation of MHC Class II Expression through Inhibition of CIITA Transcription by Lytic Transactivator Zta during Epstein-Barr Virus Reactivation
J. Immunol., February 15, 2009; 182(4): 1799 - 1809.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. H. Dreyfus, A. J. Gross, and D. Thorley-Lawson
Role of T Cells in EBV-Infected Systemic Lupus Erythematosus Patients
J. Immunol., September 15, 2005; 175(6): 3460 - 3461.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. DiPerna, J. Stack, A. G. Bowie, A. Boyd, G. Kotwal, Z. Zhang, S. Arvikar, E. Latz, K. A. Fitzgerald, and W. L. Marshall
Poxvirus Protein N1L Targets the I-{kappa}B Kinase Complex, Inhibits Signaling to NF-{kappa}B by the Tumor Necrosis Factor Superfamily of Receptors, and Inhibits NF-{kappa}B and IRF3 Signaling by Toll-like Receptors
J. Biol. Chem., August 27, 2004; 279(35): 36570 - 36578.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Keating, S. Prince, M. Jones, and M. Rowe
The Lytic Cycle of Epstein-Barr Virus Is Associated with Decreased Expression of Cell Surface Major Histocompatibility Complex Class I and Class II Molecules
J. Virol., July 25, 2002; 76(16): 8179 - 8188.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. M. Tato and C. A. Hunter
Host-Pathogen Interactions: Subversion and Utilization of the NF-{kappa}B Pathway during Infection
Infect. Immun., July 1, 2002; 70(7): 3311 - 3317.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Tardif, M. Savard, L. Flamand, and J. Gosselin
Impaired Protein Kinase C Activation/Translocation in Epstein-Barr Virus-infected Monocytes
J. Biol. Chem., June 28, 2002; 277(27): 24148 - 24154.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Lu, S.-Y. Chen, H.-H. Chua, Y.-S. Liu, Y.-T. Huang, Y. Chang, J.-Y. Chen, T.-S. Sheen, and C.-H. Tsai
Upregulation of Tyrosine Kinase TKT by the Epstein-Barr Virus Transactivator Zta
J. Virol., August 15, 2000; 74(16): 7391 - 7399.
[Abstract] [Full Text]


Home page
BloodHome page
D. H. Dreyfus, M. Nagasawa, C. A. Kelleher, and E. W. Gelfand
Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells
Blood, July 15, 2000; 96(2): 625 - 634.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.